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toward PLHIV. However, little is known in devel-
oping countries about whether perceptions and 
experiences of stigma among PLHIV have changed 
following increased access to ART. 
In response to this gap, researchers from the Ho-
rizons Program and the International Centre for 
Reproductive Health undertook an observational 
study in Mombasa, Kenya, to document changes in 
internalized and experienced stigma in a cohort of 
HIV-infected persons over a 12-month period after 
initiating ART. The study was conducted in col-
laboration with Coast Province General Hospital, 

















Changes in stigma among a Cohort of 
PeoPle on antiretroviral theraPy: 
findings from mombasa, Kenya
To read more about this study, go to 
www.popcouncil.org/horizons/projects/Kenya_HAARTMombasa.htm
A longitudinal study of 
patients on antiretroviral 
therapy (ART) found that 
levels of internalized stigma 
decreased after 12 months 
on treatment. Participants 
also disclosed to a greater 
number of family members. 
Despite these positive 
changes, internalized stigma 
remains a problem for many 
respondents and warrants 
increased stigma reduction 
activities in the community.
Stigma has been a reality in the lives of people living with HIV (PLHIV) since the inception of the AIDS epidemic. PLHIV have reported 
experiencing stigma in a variety of ways including 
isolation, rejection, withholding of emotional and 
financial support, denial of health services, and loss 
of employment. These manifestations of stigma can 
have profound implications for the health, psycho-
social well-being, and utilization of health services 
by PLHIV (UNAIDS 2001; Alubo et al. 2002).   
In the industrialized world, the availability of ART 
and a subsequent change in perception of AIDS as 
a chronic manageable disease has coincided with 
a decrease in stigma and discrimination directed 











The researchers conducted semi-struc-
tured interviews at health facilities with 
a cohort of HIV-infected persons prior 
to starting ART and after 12 months on 
treatment. The interviewers were trained 
in building rapport, maintaining confi-
dentiality, and using non-judgemental 
data collection techniques. All patients 
received standard adherence counseling 
consisting of three preparatory sessions 
before the initiation of ART and ongoing counseling 
for the duration of the study. 
Internalized stigma was measured using a 16-item scale 
(Cronbach’s alpha 0.81; possible range of scores 16–64) 
adapted from the HIV Stigma scale (Berger, Ferrans, 
and Lashley 2001). The scale covered four domains: 
personalized stigma, disclosure concerns, negative 
self-image, and concern with public attitudes toward 
PLHIV. Using a 4-point Likert scale, respondents indi-
cated their level of agreement with each item (strongly 
disagree, disagree, agree, and strongly agree). The scores 
were categorized into minimal to low stigma (16–40) 
and moderate to high stigma (41–64). Experienced 
stigma within the family, community, and workplace 
was assessed by asking respondents about people's re-
actions after they disclosed their HIV status in these 
settings. Respondents were also asked whether they 
received any form of support or encouragement from 
these individuals. 
The Ethical Review Board of Kenyatta National 
Hospital, Kenya, and the Institutional Review 
Board of the Population Council, USA, gave ethi-
cal approval for the study. All interviewees provid-
ed informed consent prior to the interviews.  
Sociodemographic Characteristics 
A total of 181 participants were followed over 12 
months and completed both baseline and endline 
interviews. Most of the sample was female (63 per-
cent). The mean age was 37 years (SD 7.93) and 
84 percent had completed primary school. Almost 
half (48 percent) were married or cohabitating, 15 
percent were single, 14 percent were divorced or 
separated, and 23 percent were widowed.  
Key Findings
Internalized stigma declined signifi-
cantly after 12 months on treatment, 
particularly among women. Nearly 
three-quarters (73 percent) of respon-
dents reported moderate to high inter-
nalized stigma at baseline. As shown 
in Figure 1, the proportion reporting 
moderate to high internalized stigma 
declined significantly after 12 months 
on treatment (p < .001); correspond-
ingly, the proportion reporting minimal to low stigma 
increased significantly at follow up. 
At baseline more women than men reported moderate 
to high internalized stigma (71 vs. 65 percent). After 
12 months on treatment, there were significant declines 
in the proportion of both women (71 vs. 60 percent; p 
= 0.018) and men (65 vs. 51 percent; p = 0.007) who 
reported moderate to high internalized stigma. 
When examining mean scores to measure internalized 
stigma, women reported significantly higher mean 
scores compared to men at baseline (45.7 vs. 43.3; p 
= 0.035). The mean scores declined for both groups, 
although the decline was greater among women. At 
follow up, women and men had similar mean scores 
(41.78 vs. 40.34; p = 0.215). 
There was no association between internalized stigma 
and age or marital status. 
Horizons conducts global operations 
research to improve HIV/AIDS 
prevention, care, and support 
programs. Horizons is implemented by 
the Population Council in partnership 
with the International Center for 
Research on Women (ICRW), PATH, 
the International HIV/AIDS Alliance, 
Tulane University, Family Health 
International, and Johns Hopkins 
University. 
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Figure 1  Classification of participants by internalized
























Most respondents who had disclosed to someone in the 
community reported that they had received some form 
of support; less than 10 percent reported a negative 
reaction. Very few respondents (less than 4 percent) 
who disclosed their HIV status to someone in the com-
munity reported experiencing a stigmatizing event in 
public, such as being called a derogatory name or being 
refused service in a restaurant. 
The most frequently mentioned reasons at baseline 
for not disclosing their HIV status to someone in the 
community were fear of verbal abuse, gossip, and being  
isolated and these fears did not diminish at endline.  
Although it not a principal reason for not disclosing, 
the proportion of respondents who feared that they or 
their family would be rejected decreased significantly at 
endline (15 vs. 5 percent; p = 0.035). 
Disclosure at the workplace was low, yet participants 
received positive support from the individuals they 
disclosed to. At baseline 30 percent (n = 54) of the 
respondents were employed. This figure increased to 35 
percent (n = 64) a year later. Disclosure to colleagues 
at work by employed respondents increased from 15 
percent at baseline to 22 percent at endline, but the 
difference was not statistically significant. Overall, col-
leagues and employers were supportive of participants, 
who had dsiclosed providing mostly psychological and 
physical support. The most commonly mentioned 
reasons for not disclosing at the workplace were fear 
Participants disclosed to a significantly greater num-
ber of family members after 12 months on treatment. 
At baseline, the vast majority (85 percent) of respon-
dents had disclosed their HIV status to someone in 
the family. While this increased slightly to 90 percent, 
the difference was not statistically significant. But the 
number of family members to whom participants had 
disclosed their HIV status increased significantly over 
time from a median of two family members at baseline 
to a median of three family members at follow up (p < 
0.001).  
Among married or cohabiting respondents disclosure 
to spouses was high at baseline (80 percent; n = 101) 
and at follow up (83 percent; n = 88). Figure 2 shows 
changes in disclosure rates to other family members. At 
both baseline and endline, disclosure was most often 
to siblings and parents. Disclosure to all categories of 
family members increased at endline, but the difference 
was only statistically significantly to parents (p = 0.05) 
and children (p = 0.004).  
Positive support from family members was very high 
at baseline and remained high at endline. Study par-
ticipants who had disclosed their HIV status to family 
members were asked about their relatives' reactions at 
baseline and endline. During both interviews, nearly 
all respondents reported that they had received positive 
support from at least one family member. Emotional 
support was the most frequently reported type of sup-
port the participants received followed by financial sup-
port and physical care. Siblings and spouses/partners 
were the most frequently cited source of support in the 
family. Less than 10 percent reported having experi-
enced a negative reaction from a family member. These 
included “don’t visit me,” “don’t touch me,” “don’t eat 
or sit with me,” “deserted me,” “verbally abused me,” 
“threw me out of the house,” and “hid me in a corner.”
There was no change in disclosure rates to community 
members. At baseline, only about a fourth of respon-
dents disclosed to a community member and there was 
little change at endline. Study participants mainly dis-
closed to friends, neighbors, and religious leaders. The 
proportion of respondents disclosing their HIV status 
to  a neighbor, health worker, and in a PLHIV support 
group increased after 12 months on treatment, but the 
differences were not statistically significant.
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*p = 0.05; ** p = 0.004  
Note: Multiple responses permitted
Figure 2  Disclosure to family members at baseline
  and follow up 
















of rumors/gossip, fear of isolation, and fear of losing 
their job. Overall, there were no significant differences 
between baseline and endline regarding the reasons for 
not disclosing in the workplace, except for a significant 
decrease in fear of verbal abuse (17 vs. 6 percent; p < 
0.05).
Conclusions
The study found that levels of internalized stigma 
decreased among participants. Before initiating ART, 
many study participants reported a moderate to high 
level of internalized stigma. However, after 12 months 
on ART, the proportion of patients in this category de-
clined significantly. In addition, the study revealed that 
participants disclosed to a significantly greater number 
of family members over time, especially to children. 
But there was no change in disclosure rates in the com-
munity or at the workplace.  
Only a small proportion of participants reported expe-
riencing a negative or stigmatizing event in the family, 
community, or at the workplace. Within the family 
nearly all participants reported receiving psychological, 
financial, and/or physical support. Fears of rejection by 
the community and of verbal abuse at the workplace 
declined significantly at follow up.
Due to a lack of a control group, it is not possible to 
conclude that access to ART reduced internalized stig-
ma and increased disclosure to more family members. 
But the data do indicate a strong association between 
initiation of ART and more favorable stigma and dis-
closure outcomes. A possible explanation for this as-
sociation is that being on ART improved participants’ 
physical health, which contributed to improvements 
in their self-image and self-worth, and reductions in 
their fears of disclosure and negative public attitudes. 
It is also likely that ongoing stigma-reduction efforts in 
Mombasa, such as red-ribbon campaigns and informa-
tion dissemination about transmission, have contrib-
uted to the study’s positive outcomes.  
In this particular setting where access to ART has in-
creased greatly, family members appear to be the easiest 
for participants to approach to disclose their serostatus, 
whereas the community and workplace remain much 
more formidable outlets. More research using qualita-
tive methods is needed to better understand the reasons 
for non-disclosure in the community with regard to 
privacy and trust issues, and expectations of support 
from workmates and the community. 
Finally, although the researchers observed a reduction 
in internalized stigma, a substantial proportion of both 
women and men reported moderate to high levels at 
follow up. Therefore, in addition to increased and sus-
tained availability of ART, more stigma reduction inter-
ventions are warranted in this community.  
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